Clorox (NYSE:CLX) Price Target Lowered to $95.00 at JPMorgan Chase & Co.

Key Points

• JPMorgan cut its price target on Clorox to $95 and kept an "underweight" rating, joining several brokers that trimmed targets and leaving the consensus analyst view at "Reduce" with an average target of $105.80.
• Shares fell about 10.1% to $86.68 on heavy volume after Clorox trimmed its FY2026 sales/outlook, with management citing weaker demand and rising input costs—management said the guidance cut was the primary driver of the selloff.
• Operationally, Clorox beat Q3 EPS expectations ($1.64 vs. $1.55) with revenue roughly in line, but set FY2026 EPS guidance of $5.45–5.65 versus analysts' ~5.87 estimate; the stock trades at a P/E of ~14.2 and a market cap near $10.5 billion.

Clorox (NYSE:CLX - Get Free Report) had its target price cut by equities researchers at JPMorgan Chase & Co. from $99.00 to $95.00 in a report released on Friday,Benzinga reports. The brokerage presently has an "underweight" rating on the stock. JPMorgan Chase & Co.'s price target indicates a potential upside of 9.60% from the stock's current price.

Several other analysts have also recently weighed in on CLX. Wells Fargo & Company cut their price objective on Clorox from $110.00 to $100.00 and set an "equal weight" rating on the stock in a research report on Friday. TD Cowen raised their target price on Clorox from $98.00 to $111.00 and gave the company a "hold" rating in a research note on Tuesday, March 31st. Citigroup dropped their price target on Clorox from $115.00 to $110.00 and set a "neutral" rating on the stock in a research report on Wednesday, April 15th. UBS Group set a $96.00 price objective on Clorox in a report on Friday. Finally, Rothschild & Co Redburn set a $117.00 price objective on Clorox in a research report on Friday, February 13th. One analyst has rated the stock with a Buy rating, twelve have issued a Hold rating and four have assigned a Sell rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Reduce" and an average target price of $105.80.

Clorox Trading Down 10.1%

Shares of CLX stock traded down $9.77 during trading hours on Friday, reaching $86.68. The company's stock had a trading volume of 10,070,124 shares, compared to its average volume of 2,396,157. The company has a current ratio of 0.74, a quick ratio of 0.48 and a debt-to-equity ratio of 71.03. The stock has a market capitalization of $10.48 billion, a P/E ratio of 14.16, a P/E/G ratio of 0.47 and a beta of 0.65. The firm's fifty day simple moving average is $108.21 and its 200 day simple moving average is $108.82. Clorox has a one year low of $86.01 and a one year high of $140.24.

Clorox (NYSE:CLX - Get Free Report) last posted its earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, topping the consensus estimate of $1.55 by $0.09. Clorox had a net margin of 11.17% and a return on equity of 383.01%. The firm had revenue of $1.67 billion during the quarter, compared to analysts' expectations of $1.67 billion. During the same period last year, the company posted $1.45 EPS. The company's quarterly revenue was up .1% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Equities research analysts expect that Clorox will post 5.87 EPS for the current year.

Institutional Investors Weigh In On Clorox

Several hedge funds have recently added to or reduced their stakes in CLX. State Street Corp raised its position in shares of Clorox by 3.5% in the 3rd quarter. State Street Corp now owns 8,434,277 shares of the company's stock worth $1,039,946,000 after purchasing an additional 282,794 shares during the last quarter. Invesco Ltd. grew its position in Clorox by 22.1% during the 4th quarter. Invesco Ltd. now owns 4,880,341 shares of the company's stock valued at $492,085,000 after purchasing an additional 884,751 shares during the last quarter. Geode Capital Management LLC grew its position in Clorox by 0.3% during the 4th quarter. Geode Capital Management LLC now owns 3,172,233 shares of the company's stock valued at $318,613,000 after purchasing an additional 10,060 shares during the last quarter. Van ECK Associates Corp increased its stake in Clorox by 15.7% during the 4th quarter. Van ECK Associates Corp now owns 3,136,405 shares of the company's stock valued at $316,244,000 after purchasing an additional 426,433 shares in the last quarter. Finally, Two Sigma Investments LP increased its stake in Clorox by 33.8% during the 3rd quarter. Two Sigma Investments LP now owns 1,740,175 shares of the company's stock valued at $214,564,000 after purchasing an additional 439,797 shares in the last quarter. 78.53% of the stock is owned by institutional investors.

Key Headlines Impacting Clorox

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Q3 beat on the headline numbers: Clorox reported $1.64 EPS vs. consensus ~ $1.55 and revenue roughly in line at ~$1.67B — showing the underlying business still delivered a modest beat. Clorox Beats Q3
• Neutral Sentiment: Management emphasized strategic innovation and selective acquisitions as a path to longer‑term growth, which could support recovery over time but won’t offset near‑term demand/cost headwinds immediately. Earnings Call Highlights
• Negative Sentiment: Company trimmed its fiscal outlook and cut FY2026 sales guidance (reported as a ~-6% sales outlook in market coverage), citing weaker demand and rising costs — the guidance reduction is the primary driver of the selloff and new 52‑week lows. Guidance Cut / 52-Week Low
• Negative Sentiment: Major brokerages trimmed price targets (Wells Fargo to $100; Morgan Stanley to $97) and kept neutral/equal‑weight stances, increasing near‑term selling pressure. Wells Fargo Price Target Morgan Stanley Price Target
• Negative Sentiment: Press reports and the company update noted weaker demand and higher input costs that prompted a lower annual profit forecast, reinforcing investor concerns about near‑term margins. WSJ: Cuts Earnings Outlook

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company's flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox's diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.